期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
血清TLR4和VEGFA表达对糖尿病视网膜病变的临床诊断及预后价值评估 被引量:3
1
作者 闫秀丽 王钦 陆相庆 《国际眼科杂志》 CAS 北大核心 2023年第10期1709-1713,共5页
目的:探讨Toll样受体4(TLR4)、血管内皮生长因子A(VEGFA)在糖尿病视网膜病变(DR)患者血清中的表达情况及临床意义。方法:选取2021-01/2022-01本院收治的183例2型糖尿病(T2DM)患者为研究对象,分为非糖尿病视网膜病变(NDR)组(54例),增殖... 目的:探讨Toll样受体4(TLR4)、血管内皮生长因子A(VEGFA)在糖尿病视网膜病变(DR)患者血清中的表达情况及临床意义。方法:选取2021-01/2022-01本院收治的183例2型糖尿病(T2DM)患者为研究对象,分为非糖尿病视网膜病变(NDR)组(54例),增殖性糖尿病视网膜病变(PDR)组(68例)和非增殖性糖尿病视网膜病变(NPDR)组(61例)。同期按照年龄、性别分层随机选择70例于本院进行健康体检志愿者作为对照组。出院后随访1a,根据DR患者是否发生视力残疾,分为预后不良组(40例)与预后良好组(89例)。采用酶联免疫吸附法(ELISA)检测血清中TLR4、VEGFA水平;通过Logistic回归分析DR发生的影响因素;利用受试者工作特征曲线(ROC)分析血清TLR4、VEGFA水平诊断DR及预测预后的临床价值。结果:对照组、NDR组、PDR组和NPDR组间TLR4、VEGFA水平比较均具有差异(F=935.753、516.936,均P<0.05),各组两两比较均具有差异(P<0.05)。预后不良组患者血清中TLR4、VEGFA表达水平均高于预后良好组(P<0.01)。Logistic回归分析结果显示,TLR4、VEGFA、病程、HbA1c均是DR发生的危险因素(P<0.05);ROC结果显示,血清TLR4、VEGFA水平及二者联合预测DR的AUC分别为0.869、0.862、0.931,血清TLR4、VEGFA水平及二者联合预测DR患者视力残疾的AUC分别为0.864、0.863、0.938。结论:DR患者血清中TLR4、VEGFA表达均上调,二者联合检测可作为评估DR发生及预后不良的潜在指标。 展开更多
关键词 糖尿病视网膜病变 血清Toll样受体4(TLR4) 血管内皮生长因子A(VEGFA)
下载PDF
Identification of microRNAs and messenger RNAs involved in human umbilical cord mesenchymal stem cell treatment of ischemic cerebral infarction using integrated bioinformatics analysis 被引量:13
2
作者 Yin-Meng Qu Xin Sun +3 位作者 xiu-li yan Hang Jin Zhen-Ni Guo Yi yang 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第9期1610-1616,共7页
In recent years,a large number of differentially expressed genes have been identified in human umbilical cord mesenchymal stem cell(hUMSC)transplants for the treatment of ischemic cerebral infarction.These genes are i... In recent years,a large number of differentially expressed genes have been identified in human umbilical cord mesenchymal stem cell(hUMSC)transplants for the treatment of ischemic cerebral infarction.These genes are involved in various biochemical processes,but the role of microRNAs(miRNAs)in this process is still unclear.From the Gene Expression Omnibus(GEO)database,we downloaded two microarray datasets for GSE78731(messenger RNA(mRNA)profile)and GSE97532(miRNA profile).The differentially expressed genes screened were compared between the hUMSC group and the middle cerebral artery occlusion group.Gene ontology enrichment and pathway enrichment analyses were subsequently conducted using the online Database for Annotation,Visualization,and Integrated Discovery.Identified genes were applied to perform weighted gene co-suppression analyses,to establish a weighted co-expression network model.Furthermore,the protein-protein interaction network for differentially expressed genes from turquoise modules was built using Cytoscape(version 3.40)and the most highly correlated subnetwork was extracted from the protein-protein interaction network using the MCODE plugin.The predicted target genes for differentially expressed miRNAs were also identified using the online database starBase v3.0.A total of 3698 differentially expressed genes were identified.Gene ontology analysis demonstrated that differentially expressed genes that are related to hUMSC treatment of ischemic cerebral infarction are involved in endocytosis and inflammatory responses.We identified 12 differentially expressed miRNAs in middle cerebral artery occlusion rats after hUMSC treatment,and these differentially expressed miRNAs were mainly involved in signaling in inflammatory pathways,such as in the regulation of neutrophil migration.In conclusion,we have identified a number of differentially expressed genes and differentially expressed mRNAs,miRNA-mRNAs,and signaling pathways involved in the hUMSC treatment of ischemic cerebral infarction.Bioinformatics and interaction analyses can provide novel clues for further research into hUMSC treatment of ischemic cerebral infarction. 展开更多
关键词 nerve REGENERATION ischemic cerebral infarction human umbilical cord mesenchymal STEM CELL TREATMENT bioinformatics analysis DIFFERENTIALLY EXPRESSED genes DIFFERENTIALLY EXPRESSED mRNAs inflammatory response STEM CELL therapy weighted gene co-suppression analysis WGCNA protein-protein interaction network PPI hUMSC neural REGENERATION
下载PDF
Huangqi Decoction,a compound Chinese herbal medicine,inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-βaxis 被引量:4
3
作者 Ben-sheng Dong Fu-qun Liu +5 位作者 Wen-na yang Xiao-dong Li Miao-juan Shi Mao-rong Li xiu-li yan Hui Zhang 《Journal of Integrative Medicine》 SCIE CAS CSCD 2023年第1期47-61,共15页
Objective Huangqi Decoction(HQD),a classical traditional Chinese medicine formula,has been used as a valid treatment for alleviating liver fibrosis;however,the underlying molecular mechanism is still unknown.Although ... Objective Huangqi Decoction(HQD),a classical traditional Chinese medicine formula,has been used as a valid treatment for alleviating liver fibrosis;however,the underlying molecular mechanism is still unknown.Although our previous studies showed that microRNA-663a(miR-663a)suppresses the proliferation and activation of hepatic stellate cells(HSCs)and the transforming growth factor-β/small mothers against decapentaplegic(TGF-β/Smad)pathway,whether long noncoding RNAs(lncRNAs)are involved in HSC activation via the miR-663a/TGF-β/Smad signaling pathway has not yet reported.The present study aimed to investigate the roles of lncRNA lnc-C18orf26-1 in the activation of HSCs and the mechanism by which HQD inhibits hepatic fibrosis.Methods The expression levels of lnc-C18orf26-1,miR-663a and related genes were measured by quantitative reverse transcription-polymerase chain reaction.HSCs were transfected with the miR-663a mimic or inhibitor and lnc-C18orf26-1 small interfering RNAs.The water-soluble tetrazolium salt-1 assay was used to assess the proliferation rate of HSCs.Changes in lncRNA expression were evaluated in miR-663a-overexpressing HSCs by using microarray to identify miR-663a-regulated lncRNAs.RNA hybrid was used to predict the potential miR-663a binding sites on lncRNAs.Luciferase reporter assays further confirmed the interaction between miR-663a and the lncRNA.The expression levels of collagen α-2(I)chain(COL1A2),α-smooth muscle actin(α-SMA)and TGF-β/Smad signaling pathway-related proteins were determined using Western blotting.Results Lnc-C18orf26-1 was upregulated in TGF-β1-activated HSCs and competitively bound to miR-663a.Knockdown of lnc-C18orf26-1 inhibited HSC proliferation and activation,downregulated TGF-β1-stimulatedα-SMA and COL1A2 expression,and inhibited the TGF-β1/Smad signaling pathway.HQD suppressed the proliferation and activation of HSCs.HQD increased miR-663a expression and decreased lnc-C18orf26-1 expression in HSCs.Further studies showed that HQD inhibited the expression of COL1A2,α-SMA,TGF-β1,TGF-βtype I receptor(TGF-βRI)and phosphorylated Smad2(p-Smad2)in HSCs,and these effects were reversed by miR-663a inhibitor treatment.Conclusion Our study identified lnc-C18orf26-1 and miR-663a as promising therapeutic targets for hepatic fibrosis.HQD inhibits HSC proliferation and activation at least partially by regulating the lnc-C18orf26-1/miR-663a/TGF-β1/TGF-βRI/p-Smad2 axis. 展开更多
关键词 Longnoncoding RNA-C18orf26-1 MicroRNA-663a Transforming growth factor-β Hepatic stellate cells Huangqi Decoction
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部